rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Spruce Biosciences, Inc.

SPRB · Nasdaq

Health CareBiotechnologyNot moving yet

SPRB stood above a rising 150-day average in 15 of the last 50 weekly readings, and has been out of that trend for the last 35 weeks. It is 23.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 35
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
64 (+35)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 15 of 50 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$9,158$0$8,486Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders64+35 on the quarter
New · exited39 · 4
Reported value$108.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
AIGH Capital Management LLCnew · filed 7 Aug 2026250,000$13.5M+250,000
ORBIMED ADVISORS LLCnew · filed 14 Aug 2026200,000$10.8M+200,000
BlackRock, Inc.added · filed 7 Aug 2026187,836$10.1M+170,898+1009.0%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026160,981$8.7M+49,093+43.9%
Ikarian Capital, LLCunchanged · filed 14 Aug 2026121,356$6.6M00.0%
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026119,331$6.4M+119,331
Alyeska Investment Group, L.P.added · filed 14 Aug 202681,671$4.4M+30,000+58.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202670,548$3.8M+57,659+447.4%
ADAR1 Capital Management, LLCadded · filed 14 Aug 202667,717$3.7M+9,117+15.6%
Cable Car Capital, LPnew · filed 14 Aug 202660,000$3.2M+60,000
31 Mar 2023 – 30 Jun 2026
43362Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Adrian W. Quartel Company insiderChief Medical Officer · last 27 Jul 20260 · 0
Javier B. Szwarcberg Company insiderCHIEF EXECUTIVE OFFICER · last 30 Jun 20260 · 0
Camilla Simpson V Company insiderDirector · last 21 May 20260 · 2
Daniel K. Spiegelman Company insiderDirector · last 21 May 20260 · 0
Keli Walbert Company insiderDirector · last 21 May 20260 · 0
Michael G. Grey Company insiderExecutive Chairman · last 21 May 20260 · 0
Percival Barretto-Ko Company insiderDirector · last 21 May 20260 · 0
Corwin Dale Hooks Company insiderChief Commercial Officer · last 9 Mar 20260 · 0
Samir M. Gharib Company insiderPRESIDENT AND CFO · last 15 Dec 20250 · 0
Douglas Kirk Ways Company insiderInterim Chief Medical Officer · last 11 Dec 20250 · 0
Parkman Healthcare Partners Llc Company insider10% owner · last 6 Oct 20252 · 2
Bali Muralidhar Company insiderDirector · last 22 Jul 20251 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-85.0%
Share count trendFY 2025 · to 3 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$48.9M

Analyst forecasts

No analyst forecasts yet.